Skip to main content
OpenTrials
Completed

NCT Number: NCT01766973

Decoding Chronic Pain With fMRI

Recent evidence suggests that chronic pain is associated with abnormal connectivity between brain regions associated with the processing of pain. We aim to test the diagnostic power of resting state functional magnetic resonance imaging (MRI) to diagnose patients with chronic back pain. Using new methods of image acquisition and analysis we aim to develop a computational method to correctly classify patients and matched control subjects.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Addenbrookes Hospital

Cambridge, CB2 0QQ, United Kingdom

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 18-60
  • pain > 6months
  • right-handed
  • non-smoking
  • mechanical back pain

Exclusion criteria

  • significant neurological or psychiatric disease
  • major systemic illness
  • MRI exclusion criteria

Treatment and study plan

Primary outcomes

  1. Functional brain connectivity

    Time frame: 6 months

    Assessed by fMRI

Sponsors and collaborators

Lead sponsor

University of Cambridge

Other

Registry information

Official study title

Observational Study to Determine Abnormalities in Resting State fMRI in Chronic Back Pain.

Important dates

Study start
2013
Primary completion
2016
Study completion
2018
First posted
Jan 11, 2013
Registry last updated
Jun 8, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.